Compounds > caffeic acid phenethyl ester
Page last updated: 2024-09-02

caffeic acid phenethyl ester and Complications of Diabetes Mellitus

caffeic acid phenethyl ester has been researched along with Complications of Diabetes Mellitus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Bassossy, HM; Fahmy, A; Hassan, NA; Mahmoud, MF1
Acquaviva, R; Di Giacomo, C; Pittalà, V; Romeo, G; Salerno, L; Sorrenti, V1

Reviews

1 review(s) available for caffeic acid phenethyl ester and Complications of Diabetes Mellitus

ArticleYear
Therapeutic Potential of Caffeic Acid Phenethyl Ester (CAPE) in Diabetes.
    Current medicinal chemistry, 2018, Volume: 25, Issue:37

    Topics: Animals; Antioxidants; Caffeic Acids; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Disease Progression; Humans; Oxidative Stress; Phenylethyl Alcohol; Polyphenols

2018

Other Studies

1 other study(ies) available for caffeic acid phenethyl ester and Complications of Diabetes Mellitus

ArticleYear
Caffeic acid phenethyl ester, a 5-lipoxygenase enzyme inhibitor, alleviates diabetic atherosclerotic manifestations: effect on vascular reactivity and stiffness.
    Chemico-biological interactions, 2014, Apr-25, Volume: 213

    Topics: Animals; Aorta; Atherosclerosis; Blood Pressure; Body Weight; Caffeic Acids; Diabetes Complications; Immunohistochemistry; Insulin; Lipoxygenase Inhibitors; Male; Phenylethyl Alcohol; Rats; Rats, Wistar; Vascular Stiffness; Vasoconstriction

2014